Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Fungal Group Zygomycota

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...

Fungal Phylum Microsporidia

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...

Antifungal Agents

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Procalcitonin-An Enigmatic Anxiolytic Biomarker.

JAMA network open·2026

Same author

Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Same author

Characterizing the in vitro and in vivo effect of bicarbonate on azithromycin activity against Acinetobacter baumannii.

PloS one·2026

Same author

Universal high-dose meropenem for antimicrobial-resistant Gram-negative infections: evidence or overreach?

European journal of hospital pharmacy : science and practice·2026

Same author

Evidence Over Eminence: Rethinking Specialty Guidelines Amid the ATS-IDSA Debate.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Same author

A Once-in-a-Generation Transformation at an Academic Public Hospital During Federal Funding Uncertainty.

Journal of healthcare leadership·2026

Search research articles

Related Experiment Video

Updated: May 25, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Future directions in mucormycosis research.

Dimitrios P Kontoyiannis¹, Russell E Lewis, Oliver Lortholary

¹Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. dkontoyi@mdanderson.org

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

|January 17, 2012

Summary

Mucormycosis is a serious opportunistic infection affecting immunocompromised individuals. This article reviews its epidemiology, pathogenesis, diagnosis, and challenges in clinical study design for this fungal infection.

More Related Videos

Rapid Freezing using Sandwich Freezing Device for Good Ultrastructural Preservation of Biological Specimens in Electron Microscopy

Rapid Freezing using Sandwich Freezing Device for Good Ultrastructural Preservation of Biological Specimens in Electron Microscopy

Published on: July 19, 2021

Related Experiment Videos

Last Updated: May 25, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Rapid Freezing using Sandwich Freezing Device for Good Ultrastructural Preservation of Biological Specimens in Electron Microscopy

Rapid Freezing using Sandwich Freezing Device for Good Ultrastructural Preservation of Biological Specimens in Electron Microscopy

Published on: July 19, 2021

Area of Science:

Mycology
Infectious Diseases
Immunology

Background:

Mucormycosis is a life-threatening fungal infection.
It primarily affects severely immunocompromised hosts.
Understanding its complexities is crucial for patient outcomes.

Purpose of the Study:

To provide a comprehensive overview of mucormycosis.
To discuss recent advancements in the field.
To highlight challenges in clinical research.

Main Methods:

Review of current literature on mucormycosis.
Analysis of epidemiological trends.
Discussion of immunopathogenesis and virulence factors.

Main Results:

Mucormycosis epidemiology is evolving, particularly in specific patient groups.
Immunopathogenesis involves complex host-fungal interactions.
Molecular virulence studies offer insights into infection mechanisms.

Conclusions:

Early diagnosis and effective treatment remain critical.
Pitfalls in clinical study design can hinder progress.
Further research is needed to improve management strategies for mucormycosis.